Unit volume climbed 30% Y/Y to 3.9 million equivalized cases.
Gross profit grew 7% to $17.4 million, while the margin contracted 920 basis points to 38.1%, reflecting the impact of broad-based inflationary pressures.
Loss from operations for the quarter widened sharply to $(14.7) million.
The company held $49.6 million in cash and equivalents as of June 30, 2022.
EPS loss for the quarter was $(0.28). Adjusted EBITDA loss for the quarter widened to $(6.4) million.
"Growth was balanced across channels as we continued to expand our distribution with new and existing customers," said CEO Amy Taylor.
Outlook: Zevia maintained its FY22 sales forecast of $177 million - $182 million, versus the consensus of $178.49 million.
The company expects Q3 sales of $46 million - $48 million, below the estimate of $52.15 million.
Price Action: ZVIA shares are trading higher by 16.22% at $3.94 on the last check Thursday.
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.